Insider Transactions in Q1 2024 at Anaptysbio, Inc (ANAB)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 26
2024
|
Daniel Faga CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
347,441
-46.38%
|
$7,296,261
$21.6 P/Share
|
Mar 25
2024
|
Daniel Faga CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.4%
|
$63,000
$21.42 P/Share
|
Mar 22
2024
|
Daniel Faga CEO |
SELL
Open market or private sale
|
Direct |
145,940
-16.25%
|
$3,210,680
$22.78 P/Share
|
Feb 16
2024
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-60.68%
|
$125,000
$25.0 P/Share
|
Feb 16
2024
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+37.76%
|
$70,000
$14.02 P/Share
|
Jan 30
2024
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,065
-76.07%
|
$70,495
$23.63 P/Share
|
Jan 08
2024
|
Daniel Faga CEO |
SELL
Open market or private sale
|
Direct |
6,866
-0.76%
|
$144,186
$21.81 P/Share
|
Jan 08
2024
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,180
-35.11%
|
$45,780
$21.81 P/Share
|
Jan 08
2024
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,305
-41.57%
|
$48,405
$21.81 P/Share
|
Jan 08
2024
|
Paul F. Lizzul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,554
-20.15%
|
$53,634
$21.81 P/Share
|
Jan 06
2024
|
Daniel Faga CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,850
+1.93%
|
-
|
Jan 06
2024
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,245
+45.79%
|
-
|
Jan 06
2024
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,545
+50.0%
|
-
|
Jan 06
2024
|
Paul F. Lizzul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,145
+32.66%
|
-
|